Overview
- 45 inspections across 44 sites are on record.
- 21 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-07-02.
At a glance
Inspections
45
Sites
44
Observations
21
Career since
Mar 2023
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Tahseen Mozaffar, M.D. | 2 Jul 2026 | Human Drugs | |
| Mark Vishnepolsky, M.D. | 9 Jun 2026 | Human Drugs | View 483 → |
| Apinya B. Vutikullird, D.O. | 12 May 2026 | Human Drugs | View 483 → |
| Jean-Claude Tardif, MD | 16 Apr 2026 | Human Drugs | |
| Banner Health IRB | 31 Mar 2026 | Medical Devices & Rad Health |
Sites inspected
Tahseen Mozaffar, M.D.Irvine, United States1 insp.
Mark Vishnepolsky, M.D.Las Vegas, United States1 insp.
Apinya B. Vutikullird, D.O.Long Beach, United States1 insp.
Jean-Claude Tardif, MDMontreal, Canada1 insp.
Banner Health IRBPhoenix, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Andra Lepnis2 shared
Farwa Z Razvi2 shared
Jose A Leyva2 shared
Samson O Oluseye2 shared
Christina D Mello2 shared
Saaman Habibi1 shared
Korina Serrano1 shared
Audrey J Yarbrough1 shared
Linh Tu1 shared
Raman K Kaushal1 shared
Full investigator report
Get the verbatim findings behind Lan T Tran's 21 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site